伦敦初创公司Limbic近期在A轮融资中成功筹集了1400万美元，此举将加速其人工智能治疗助理产品在美国市场的推广。本轮融资由知名风投公司Khosla Ventures牵头，知名投资机构Gaingels和Illusian也参与其中，显示出市场对Limbic技术的高度期待。
Limbic自2018年成立以来，一直致力于研发人工智能在心理健康领域的应用。其主打产品是一款人工智能心理健康聊天机器人，以及一款基于AI的临床转诊软件。据Sifted报道，这款聊天机器人已经在英国国家医疗服务体系（NHS）中得到广泛应用，覆盖了33%的谈话治疗服务，服务患者数量高达26万人，显示出其在实际应用中的广泛影响力和有效性。
此轮融资的资金将有助于Limbic进一步优化其AI技术，扩大服务规模，并在美国这一重要市场建立更广泛的影响力。随着心理健康问题日益受到全球关注，Limbic的创新解决方案有望为患者提供更及时、更个性化的治疗支持，同时也为医疗行业带来技术革新。
英语如下：
**News Title:** “London-based AI Mental Health Company Limbic Raises $14M in A Round, Expands to US Market”
**Keywords:** AI therapy assistant, Limbic, $14 million funding
**News Content:** London-based startup Limbic has recently secured $14 million in its A轮融资, a move that will hasten the expansion of its AI therapy assistant solution into the US market. The funding round was led by prominent venture capital firm Khosla Ventures, with participation from well-known investors Gaingels and Illusian, indicating strong market anticipation for Limbic’s technology.
Since its establishment in 2018, Limbic has focused on developing AI applications in the field of mental health. Its flagship products include an AI-powered mental health chatbot and an AI-based clinical referral software. As reported by Sifted, the chatbot has been widely adopted within the UK’s National Health Service (NHS), covering 33% of talking therapy services and assisting over 260,000 patients, demonstrating its substantial impact and effectiveness in real-world applications.
The funds from this round will enable Limbic to further refine its AI technology, scale its services, and establish a broader footprint in the crucial US market. With mental health issues gaining global prominence, Limbic’s innovative solutions are poised to offer more timely and personalized treatment support to patients while driving technological transformation in the healthcare industry.
【来源】https://sifted.eu/articles/limbic-series-a-14m-ai-chatbot-news
Views: 1